Lipocine
LPCN
#10190
Rank
NZ$31.37 M
Marketcap
NZ$5.65
Share price
2.51%
Change (1 day)
-35.93%
Change (1 year)

Revenue for Lipocine (LPCN)

Revenue in 2025 (TTM): NZ$7.37 Million

According to Lipocine's latest financial reports the company's current revenue (TTM ) is NZ$7.27 Million. In 2024 the company made a revenue of NZ$19.85 Million an increase over the revenue in the year 2023 that were of -NZ$4.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lipocine from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$7.37 M-62.84%
2024 NZ$19.85 M-540.46%
2023 -NZ$4.51 Million-672.42%
2022 NZ$0.78 M-96.67%
2021 NZ$23.63 M
2020 N/A-100%
2019 NZ$0.24 M-61.61%
2018 NZ$0.63 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
NZ$3.97 B 54,564.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$7.18 B 98,705.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
NZ$37.27 M 412.53%๐Ÿ‡บ๐Ÿ‡ธ USA